fbpx
Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
POULTRY PORK
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

.

Zoetis receives USDA conditional license for first vaccine to control Georgia 08 IB strain

DURHAM, N.C., February 7, 2014 – Zoetis Inc. has obtained a conditional license from the U.S. Department of Agriculture (USDA) to market the first commercially available vaccine for helping reduce disease caused by the Georgia 08 variant of infectious bronchitis virus (IBV) in poultry*. The vaccine is now available in Alabama, Florida, Georgia, Kentucky and Tennessee.

The USDA agreed to issue a conditional license because the modified-live vaccine fills a special need, has been shown to be safe and has demonstrated a “reasonable expectation of efficacy” against the target pathogen.

“The Georgia 08 variant has had a devastating impact on animal health, production, and profits on affected farms, with previously available vaccines providing little protection,” said Kalen Cookson, DVM, MAM, a technical services veterinarian for Zoetis.

“We set the ambitious goal in spring 2013 of having a commercial vaccine available for this contagious and costly strain in time for winter, when IBV is most prevalent. We were able to achieve this goal in only seven months, thanks to the strong support of industry and the USDA. We look forward to their continued support as we work towards a full license for the vaccine.”

First identified in Georgia in December 2007, the Georgia 08 IBV variant has since been isolated on farms in Alabama, Tennessee and Kentucky. Over the past two winters, its incidence and severity have increased dramatically, resulting in significant losses due to condemnations at processing, reduced line efficiency and additional plant measures needed to process affected birds.

Unlike other IBV strains, which typically affect the upper respiratory tract, the Georgia 08 variant primarily affects the lower tract, particularly the air sacs.  According to Dr. Cookson, lower respiratory tract infections produce fewer visible symptoms in live birds, but cause “unpleasant surprises” at processing.

“Airsacculitis is a major cause of condemnation,” he explained.  “Even when birds are salvageable, the extra time and steps required have a major impact on plant efficiency.”

In addition, he said, more severe outbreaks of the Georgia 08 strain can cause further losses due to mortalities and secondary infections from E. coli and other harmful bacteria.

The new conditionally licensed vaccine has received broad industry support, including a letter from veterinarians at four major poultry companies affected by the Georgia 08 variant.

Zoetis plans to submit additional efficacy studies of the vaccine in order to pursue a full USDA license.  For more information about the conditionally licensed vaccine and other biologicals for managing IBV, producers should contact their local Zoetis representative.

* This product license is conditional. Efficacy and potency test studies are in progress.




Posted on February 7, 2014

tags: , , ,
RELATED NEWS



You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.